Edition:
India

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

3.54USD
6 Aug 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.54
Open
--
Day's High
--
Day's Low
--
Volume
1
Avg. Vol
1,427,923
52-wk High
$7.10
52-wk Low
$1.97

Select another date:

Tue, Jul 7 2020

BRIEF-U.S. FDA Approves Qwo™ (Collagenase Clostridium Histolyticum-Aaes), The First Injectable Treatment For Cellulite

* U.S. FDA APPROVES QWO™ (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES), THE FIRST INJECTABLE TREATMENT FOR CELLULITE

BRIEF-Endo International Announces Final Tender Results Of Previously Announced Exchange Offers And Consent Solicitations

* ENDO INTERNATIONAL PLC ANNOUNCES FINAL TENDER RESULTS OF ITS PREVIOUSLY ANNOUNCED EXCHANGE OFFERS AND CONSENT SOLICITATIONS

BRIEF-Endo International Announces Final Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations

* ENDO INTERNATIONAL PLC ANNOUNCES FINAL TENDER RESULTS OF ITS PREVIOUSLY ANNOUNCED EXCHANGE OFFERS AND CONSENT SOLICITATIONS

New York charges Endo with insurance fraud over opioid claims

NEW YORK New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, adding fuel to the nation's opioid crisis.

UPDATE 1-New York charges Endo with insurance fraud over opioid claims

NEW YORK, June 10 New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, adding fuel to the nation's opioid crisis.

New York charges Endo with insurance fraud over opioid claims

NEW YORK, June 10 New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs.

BRIEF-Endo International PLC Announces Proposed Exchange Offers And Consent Solicitations

* ENDO INTERNATIONAL PLC ANNOUNCES PROPOSED EXCHANGE OFFERS AND CONSENT SOLICITATIONS

BRIEF-Endo International Reports Q1 EPS From Cont Ops Of $0.68

* Q1 DILUTED EPS FROM CONTINUING OPERATIONS 0.68 USD VERSUS 0.06 USD LOSS YEAR AGO

BRIEF-Endo Reports Q1 Adjusted Earnings Per Share $0.95

* ENDO REPORTS FIRST-QUARTER 2020 FINANCIAL RESULTS AND PROVIDES UPDATE RELATING TO COVID-19 PANDEMIC

BRIEF-Endo International Says CEO Paul V. Campanelli's FY 2019 Total Compensation Was $13.1 Mln Vs $20 Mln In 2018

* ENDO INTERNATIONAL PLC SAYS CEO PAUL V. CAMPANELLI'S FY 2019 TOTAL COMPENSATION WAS $13.1 MILLION VERSUS $20 MILLION IN 2018 - SEC FILING

Select another date: